Gastric cancer remains a considerable health burden throughout the world. The Cancer
Genome Atlas (TCGA) analysis has recently unveiled 4 genotypes of gastric cancer with …

Gastric cancer is not a top‐10 malignancy in the United States but represents one of the
most common causes of cancer death worldwide. Biological differences between tumors …

Gastric cancer (GC) is one of the most common malignancies worldwide. Most patients are
diagnosed at advanced stages due to the subtle symptoms of earlier disease and the low …

The overall 5-year survival of gastric cancer (GC) has change only little in the last decades
and it remains the fifth leading cause of cancer-related death worldwide. However, in the …

Gastric cancer remains a major unmet clinical problem with over 1 million new cases
worldwide. It is the fourth most commonly occurring cancer in men and the seventh most …

Gastric cancer (GC) is a complex disease linked to a series of environmental factors and
unhealthy lifestyle habits, and especially to genetic alterations. GC represents the second …

Gastric cancer imposes a global health burden. Although multimodal therapies have proven
to benefit patients with advanced diseases after curative surgery, the prognosis of most …

Despite some remarkable innovations and the advent of novel molecular classifications the
prognosis of patients with advanced gastric cancer (GC) remains overall poor and current …

Gastric cancer is an aggressive solid-tumor malignancy with poor prognosis. The
epidemiologic face of gastric cancer is changing and further insight into its heterogenous …

Gastric cancer (GC) is one of the most lethal and aggressive cancers, being the third cause
of cancer related death worldwide. Even with radical gastrectomy and the latest generation …